Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Enspryng ™(satralizumab-mwge)…
Press
The U.S. Food and Drug Administration today approved Uplizna (inebilizumab-cdon) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult…
Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SOLIRIS® (eculizumab) for the treatment of neuromyelitis optica spectrum disorder (NMOSD)…
The Washington Post Maybe it’s the sun, Craig Klein remembers thinking as he pondered the cause of the thrumming headache that intruded on his Florida…
The Huffington Post Victoria Jackson shuddered uncontrollably when the doctor told her and husband Bill in 2008 that their 14-year-old daughter, Ali, had an extremely…
A mother spends millions to fund research for neuromyelitis optica, which can leave patients paralyzed or blind LATimes By Sandy Banks November 28, 2009 Victoria…
Featured Videos
